Avivagen Announces Foundational Scientific and Commercial Evidence of OxC-Beta(TM) Product Published in Peer-Reviewed Journal

Stock Information for Erdene Resource Development Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Erdene Resource Development Corporation

Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA
Avivagen Announces AGM Results
Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2023
Avivagen Inc. Announces Securities for Service Agreements With CEO and CSO
Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2022
Avivagen Announces Publication of Peer-Reviewed Article in Food and Chemical Toxicology Journal
Avivagen Announces New Dairy Customer in Mexico
Avivagen Announces Receipt of Repeat Order from Asian Customer

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.